×
About 6,943 results

ALLMedicine™ Herpes Zoster Center

Research & Reviews  1,822 results

Peripheral Neurectomy With Customized Nerve Reconstruction for Periorbital Neuropathic ...
https://doi.org/10.1097/IOP.0000000000002210
Ophthalmic Plastic and Reconstructive Surgery; Kim JS, Tian J et. al.

May 24th, 2022 - To describe a novel, minimally invasive surgical technique to treat severe, intractable periorbital neuropathic pain. A retrospective analysis of patients with severe, treatment-refractory periorbital pain who underwent transection of affected sen...

Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency
https://clinicaltrials.gov/ct2/show/NCT01176006

May 20th, 2022 - Background Mutations in the Dedicator of Cytokinesis-8 (DOCK8) gene are responsible for an immunodeficiency disease characterized by: severe cutaneous and sinopulmonary infections with bacterial organisms; extensive cutaneous viral infections with...

A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Su...
https://clinicaltrials.gov/ct2/show/NCT02723773

May 19th, 2022 - This is the long-term follow-up study (ZOE-LTFU) of studies 110390 and 113077 (ZOSTER-006/022) to assess the prophylactic efficacy, safety, and immunogenicity persistence of GSK Biologicals' Herpes Zoster subunit (HZ/su) vaccine and will include a...

Infectious risk of add-on leflunomide or tacrolimus versus TNF inhibitors among patient...
https://doi.org/10.1016/j.semarthrit.2022.152019
Seminars in Arthritis and Rheumatism; Shin A, Lee JH et. al.

May 15th, 2022 - To compare infectious risk between leflunomide versus TNF inhibitors (TNFi), and between tacrolimus versus TNFi among rheumatoid arthritis (RA) patients receiving methotrexate (MTX). Using Korea National Health Insurance Service database, we condu...

Comorbidities of systemic lupus erythematosus prior to and following diagnosis in diffe...
https://doi.org/10.1177/09612033221100908
Lupus Yu CY, Kuo CF et. al.

May 11th, 2022 - Systemic lupus erythematosus (SLE) is a female-dominated autoimmune disease that can occur at any age and has a diverse course. The clinical manifestation of this disease can vary depending on the patient's age at onset. The aim of this study was ...

see more →

Guidelines  5 results

Management of herpesvirus reactivations in patients with solid tumours and hematologic ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810475
Annals of Hematology; Henze L, Buhl C et. al.

Jan 8th, 2022 - Clinical reactivations of herpes simplex virus or varicella zoster virus occur frequently among patients with malignancies and manifest particularly as herpes simplex stomatitis in patients with acute leukaemia treated with intensive chemotherapy ...

European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by...
https://doi.org/10.1111/jdv.13957
Journal of the European Academy of Dermatology and Venere... Werner RN, Nikkels AF et. al.

Nov 3rd, 2016 - Herpes zoster (HZ, shingles) is a frequent medical condition which may severely impact the quality of life of affected patients. Different therapeutic approaches to treat acute HZ are available. The aim of this European project was the elaboration...

Interventional management of neuropathic pain: NeuPSIG recommendations.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484720
Pain References; Dworkin RH, O'Connor AB et. al.

Jun 12th, 2013 - Neuropathic pain (NP) is often refractory to pharmacologic and noninterventional treatment. On behalf of the International Association for the Study of Pain Neuropathic Pain Special Interest Group, the authors evaluated systematic reviews, clinica...

Vaccines for measles, mumps, rubella, varicella, and herpes zoster: immunization guidel...
https://www.ncbi.nlm.nih.gov/pubmed/22086887
The Journal of the American Osteopathic Association; Hendriksz T, Malouf P et. al.

Dec 7th, 2011 - Although vaccinations are most commonly associated with the pediatric population, it is important for healthcare professionals to be familiar with the vaccines that are recommended for adults. The authors discuss 3 vaccines-the measles, mumps, and...

Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization ...
https://www.ncbi.nlm.nih.gov/pubmed/18528318
MMWR. Recommendations and Reports : Morbidity and Mortali... Harpaz R, Ortega-Sanchez IR et. al.

Jun 6th, 2008 - These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of a live attenuated vaccine for the prevention of herpes zoster (zoster) (i.e., shingles) and its sequelae, which was licens...

see more →

Drugs  524 results see all →

Clinicaltrials.gov  56 results

Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency
https://clinicaltrials.gov/ct2/show/NCT01176006

May 20th, 2022 - Background Mutations in the Dedicator of Cytokinesis-8 (DOCK8) gene are responsible for an immunodeficiency disease characterized by: severe cutaneous and sinopulmonary infections with bacterial organisms; extensive cutaneous viral infections with...

A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Su...
https://clinicaltrials.gov/ct2/show/NCT02723773

May 19th, 2022 - This is the long-term follow-up study (ZOE-LTFU) of studies 110390 and 113077 (ZOSTER-006/022) to assess the prophylactic efficacy, safety, and immunogenicity persistence of GSK Biologicals' Herpes Zoster subunit (HZ/su) vaccine and will include a...

A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant
https://clinicaltrials.gov/ct2/show/NCT04006808

May 9th, 2022 - The purpose of this study is to evaluate the reactogenicity, safety and immunogenicity of 2 doses of PED-HZ/su, GSK's vaccine candidate for the prevention of Herpes Zoster (HZ) in immunocompromised paediatric renal transplant recipients aged 1-17 ...

The Analgesic Effect of Electroacupuncture on Postherpetic Neuralgia
https://clinicaltrials.gov/ct2/show/NCT04560361

Apr 15th, 2022 - Postherpetic neuralgia(PHN) is the most common complication of herpes zoster, is a severe and intractable pain with a high incidence. Nearly 50% of PHN patients have experienced persistent pain for more than one year. Although it is not directly l...

A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine
https://clinicaltrials.gov/ct2/show/NCT05047770

Apr 11th, 2022 - The aim of this study is to evaluate the immune response and safety of both GlaxoSmithKline Biologicals SA's (GSK's) herpes zoster (HZ) subunit (su) vaccine in healthy adults 50 years of age (YOA) and older and quadrivalent seasonal influenza (Flu...

see more →

News  362 results

Things to Know About Shingles Vaccination for Immunocompromised Adults 19 Years and Older
https://www.medscape.com/viewarticle/970406

Mar 22nd, 2022 - In January 2022, the Centers for Disease Control and Prevention (CDC) updated recommendations for shingles (herpes zoster) vaccination to include people 19 years and older who are or will be immunocompromised. This will enable providers to vaccina...

Fast Five Quiz: Herpes Zoster Risk Factors and Prevention
https://www.medscape.com/viewarticle/964468

Feb 4th, 2022 - Herpes zoster, or shingles, is a painful viral infection that occurs via the reactivation of varicella zoster virus. Approximately 30% of the world's population will develop herpes zoster during their lifetime, making it a significant global healt...

Fast Five Quiz: Herpes Zoster Risk Factors and Prevention
https://reference.medscape.com/viewarticle/964468

Feb 4th, 2022 - Herpes zoster, or shingles, is a painful viral infection that occurs via the reactivation of varicella zoster virus. Approximately 30% of the world's population will develop herpes zoster during their lifetime, making it a significant global healt...

Herpes Zoster Vaccine Can Save Your Patients' Eyesight
https://www.medscape.com/viewarticle/966888

Jan 21st, 2022 - The first vaccine for shingles in the United States — Zostavax — was approved by the US Food and Drug Administration in 2006. The landmark study, published in the The New England Journal of Medicine in 2005, involved over 38,000 adults aged 60 yea...

Herpes Zoster Following a Nucleoside-Modified Messenger RNA COVID-19 Vaccine
https://www.mdedge.com/dermatology/article/250434/infectious-diseases/herpes-zoster-following-nucleoside-modified-messenger
Frédéric Dezoteux, MD, Édouard Massip, MBBS et. al.

Jan 5th, 2022 - Since the end of 2019, COVID-19 infection caused by SARS-CoV-2 has spread in a worldwide pandemic. The first cutaneous manifestations possibly linked to COVID-19 were reported in spring 2020.

see more →

Patient Education  8 results see all →